tetradecanoylphorbol acetate has been researched along with valrubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, LF; Chuang, RY; Israel, M; Kung, HF | 1 |
| Christiansen, H; Dam, TN; de Darkó, E; Hauge, E; Rosada, C; Stenderup, K | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and valrubicin
| Article | Year |
|---|---|
Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32).
Topics: Binding, Competitive; Cell Membrane; Doxorubicin; Drug Interactions; Enzyme Activation; Humans; Kinetics; Leukemia; Phorbol 12,13-Dibutyrate; Phosphorylation; Protein Binding; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
Topical valrubicin application reduces skin inflammation in murine models.
Topics: Acute Disease; Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Chronic Disease; Cytokines; Dermatitis, Irritant; Disease Models, Animal; Doxorubicin; Irritants; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Tetradecanoylphorbol Acetate | 2012 |